期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

左炔诺孕酮皮下埋植避孕对育龄妇女骨矿物质密度的影响 被引量：4

Effect of Levonorgestrel-Releasing Implants on Bone Mineral Density in Women of Reproductive Age
下载PDF
导出
摘要 目的:探讨应用左炔诺孕酮皮下埋植剂避孕和非激素宫内节育器(IUD)避孕对育龄妇女骨矿物质密度(BMD)的影响。方法:对比观察126例应用左炔诺孕酮皮下埋植剂的妇女和93例采用非激素IUD避孕妇女腰椎和股骨颈BMD。结果:一般检测特征在两组间类似,左炔诺孕酮皮下埋植剂平均使用期为35.2±6.7个月,与对照组相比,两组BMD差异无统计学意义。结论:左炔诺孕酮皮下埋植避孕对育龄妇女骨矿物质密度无不利影响。 Objective： To compare the bone mineral density（BMD） between users of levonorgestrel-releasing implants and nonhormonal-IUD users.Methods： A total of 126 current users of levonorgestrel-releasing implants and 93 nonhormonal-IUD users were enrolled in the study.The BMDs of the lumbar spine and femoral neck were measured by dual energy X-ray absorptiometry.Results： The demographic characteristics were similar in both groups.The mean duration of levonorgestrel-releasing implants was 35.2±6.7 months.The mean BMDs of lumbar spine and femoral neck between the users of levonorgestrel-releasing implants and the nonhormonal-IUD users were no significant differences.Conclusion： Levonorgestrel-releasing implants have no adverse effects upon BMD in women of reproductive age.
作者 盖凌 王晓青 盖萍 姜慧 刘永红
机构地区 山东省计划生育科学技术研究所优生遗传重点实验室 山东省滕州市计划生育服务站 山东省省立医院 山东省日照市东港区三庄计划生育委员会 山东省医学影像研究所
出处 《中国计划生育学杂志》 北大核心 2010年第3期166-168,共3页 Chinese Journal of Family Planning
关键词 左炔诺孕酮 皮下埋植剂 骨矿物质密度 避孕 Levonorgestrel Implanon Bone mineral density Contraception
分类号 R169.4 [医药卫生—公共卫生与预防医学]
  • 相关文献

参考文献10

  • 1Bahamondes L, Monteiro - Dantas C, Espejo - Arce X, et al. A prospective study of the forearm bone density of users of etonorgestrel - and levonorgestrel - releasing contraceptive implants. Hum Reprod, 2006, 21 (2) :466 -470.
  • 2盖凌,刘永红,盖萍,王晓青,周运胜,任正达.肌注醋酸甲羟孕酮避孕对25～40岁妇女骨矿物质密度的影响[J].中国计划生育学杂志,2008,16(3):166-168. 被引量：5
  • 3Clark MK, Sowers MR, Nichols S, et al. Bone mineral density changes over two years in first - time users of depot medroxyprogesterone acetate. Fertil Steril, 2004, 82(6) :1580 - 1586.
  • 4Naessen T, Olsson SE, Gudmundson J. Didderential effects on bone density of progestogen - only methods for contraception in premenopausal women. Contraception, 1995, 52( 1 ) :35 -39.
  • 5Beerthuizen R, Van Beek A, Massai R, et al. Bone mineral density during long - term use of the progestagen contraceptiv implant Implanon compared to a non - hormonal method of contraception. Hum Reprod, 2000, 15(1) :118 -122.
  • 6Monteiro - Dantas C, Espejo - Arce X, Lui - Filho JF, et al. A three -year longitudinal evaluation of the forearm bone density of users of etonogestrel - and levonorgestrel - releasing contraceptive implants. Reprod Health, 2007,4 : 11.
  • 7Diaz S, Reyes MV, Zepeda A, et al. Norplant implants and progesterone vaginal rings do not affect maternal bone turnover and density during lactation and after weaning. Hum Reprod, 1999, 14(10) :2499 - 2505.
  • 8Prior JC. Progesterone as a bone - trophie hormone. Endocrine Rev, 1990, 11(2) :386 -398.
  • 9Phillips A, Hahn DW, Klimek S, et al. A comparison of the potencies and activities of progestogens used in contraceptives. Contraception, 1987, 36(2) :181-192.
  • 10Cromer BA, Blair J, Mahan JD, et al. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo- Provera) , levonorgestrel (Norplant) , or oral contraceptives. J Pediatr, 1996, 129 (5) :671- 676.

二级参考文献13

  • 1Shaarawy M, El - Mallah SY, Seoudi S, et al. Effects of the long - term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling. Contraception,2006,74 (4) :297 - 302.
  • 2Kaunitz AM, Miller PD, Rice VM, et al. Bone mineral density in women aged 25 - 35 years receiving depot medroxyprogesterone acetate : recovery following discontinuation. Contraception, 2006 , 74 ( 2 ) :90-99.
  • 3Bahamondes L, Juliato CT, Villarreal M, et al. Bone mineral density in users of two kinds of once - a - month combined injectable contraceptives. Contraception ,2006,74( 3 ) :259-263.
  • 4Breitkopf Berenson AB, CR, Grady JJ, et al. Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol, 2004,103(5) :899-906.
  • 5Clark MK, Sowers MR, Nichols S, et al. Bone mineral density changes over two years in first - time users of depot medroxyprogesterone acetate. Fertil Steril, 2004,82(6) :1580-1586.
  • 6Scholes D, LaCroix AZ, lchikawa LE,et al. Injectable hormone contraception and bone density : results from a prospective study. Epidemiology,2002,13(5) :581-587.
  • 7Tang OS,Tang G,Yip PS,et al. Further evaluation on long - term depot - medroxyprogesterone acetate use and bone mineral density : a longitudinal cohort study. Contraception, 2000,62(4) :161 - 164.
  • 8Cundy T, Cornish J, Roberts H, et al. Spinal bone density in women using depot medroxyprogesterone acetate contraception. Obstet Gynecol, 1998,92(4) :569-573.
  • 9Scholes D, LaCroix AZ, lchikawa LE, et al. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med, 2005,159(2) :139 - 144.
  • 10Albertazzi P, Bottazzi M, Steel SA. Bone mineral density and depot medroxyprogesterone acetate . Contraception, 2006,73 ( 6 ) : 577-583.

共引文献4

同被引文献54

  • 1雷贞武,赵铀.女用甾体激素避孕药的临床应用研究进展[J].中国计划生育学杂志,2007,15(2):124-126. 被引量：4
  • 2孙彦荣,王树松,倪焕青,简秀坤,王俊婷,闫梅.米非司酮不同服用方法对皮下埋植术后子宫出血影响的观察[J].中国计划生育学杂志,2007,15(7):425-427. 被引量：7
  • 3Eisman J.Relevancece of pregnallcy and lactation to osteoporosis Lallce,1998,352(9127):504-505.
  • 4Pritts EA,Ryan IP,Mueller MD,et al.Angiogenic effects of Norplant contraception on endometrial histology and uterine bleeding[J].J Clin Endocrinol Metab,2005,90(4):2142-2147.
  • 5Zhao S,Chokuchat C,Zhao Y,et al.Effects of doxycycline on serum and endometrial levels of MMP-2,MMP-9 and TIMP-1 inwomen using a levonorgestrel-releasing subcutaneous implant[J].Contraception,2009,79(6):469-478.
  • 6Archer DF,Philput CB,Levine AS,et al.Effects of ethinyl estradiol and ibuprofen compared to placebo on endometrial bleeding,cervical mucus and the postcoital test in levonorgestrel subcutaneous implant users[J].Contraception,2008,78(2):106-112.
  • 7Arcangues C,Piaggio C,Brache V,et al.Effectiveness and acceptability of vitamin E and low-dose aspirin,alone or in combination,on Norplant-induced prolonged bleeding[J].Contraception,2004,70:51-462.
  • 8Massie MR,Pavez M,Fuenteabla B,et al.Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users[J].Contraception,2004,70:47-54.
  • 9Weisberg E,Hickey M,Palmer D,et al.A randomised controlled trial of treatment options for troublesome uterine bleeding in implanon users[J].Hum Reprod,2009,24(8):1852-1861.
  • 10Nasr A,Nafeh HM.Effect of etonogestrel contraceptive implant (Implanon) on portal blood flow and liver functions[J].Contraception,2009,79(3):236-239.

引证文献4

二级引证文献20

中国计划生育学杂志
2010年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部